Literature DB >> 22303019

Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation.

Christian Kliem1, Anette Merling, Marco Giaisi, Rebecca Köhler, Peter H Krammer, Min Li-Weber.   

Abstract

Curcumin is the active ingredient of the spice turmeric and has been shown to have a number of pharmacologic and therapeutic activities including antioxidant, anti-microbial, anti-inflammatory, and anti-carcinogenic properties. The anti-inflammatory effects of curcumin have primarily been attributed to its inhibitory effect on NF-κB activity due to redox regulation. In this study, we show that curcumin is an immunosuppressive phytochemical that blocks T cell-activation-induced Ca(2+) mobilization with IC(50) = ∼12.5 μM and thereby prevents NFAT activation and NFAT-regulated cytokine expression. This finding provides a new mechanism for curcumin-mediated anti-inflammatory and immunosuppressive function. We also show that curcumin can synergize with CsA to enhance immunosuppressive activity because of different inhibitory mechanisms. Furthermore, because Ca(2+) is also the secondary messenger crucial for the TCR-induced NF-κB signaling pathway, our finding also provides another mechanism by which curcumin suppresses NF-κB activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22303019      PMCID: PMC3323045          DOI: 10.1074/jbc.M111.318733

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

Authors:  R A Sharma; H R McLelland; K A Hill; C R Ireson; S A Euden; M M Manson; M Pirmohamed; L J Marnett; A J Gescher; W P Steward
Journal:  Clin Cancer Res       Date:  2001-07       Impact factor: 12.531

2.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

3.  The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair.

Authors:  E A Jones; D A Shoskes
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.

Authors:  S M Plummer; K A Holloway; M M Manson; R J Munks; A Kaptein; S Farrow; L Howells
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

5.  The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.

Authors:  Lysann Palkowitsch; Uta Marienfeld; Cornelia Brunner; Andrea Eitelhuber; Daniel Krappmann; Ralf B Marienfeld
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

6.  Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor.

Authors:  J L Dyer; S Zafar Khan; J G Bilmen; S R Hawtin; M Wheatley; M-ul-H Javed; F Michelangeli
Journal:  Cell Calcium       Date:  2002-01       Impact factor: 6.817

7.  A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp.

Authors:  P Gómez del Arco; S Martínez-Martínez; J L Maldonado; I Ortega-Pérez; J M Redondo
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

8.  A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria.

Authors:  M K Jang; D H Sohn; J H Ryu
Journal:  Planta Med       Date:  2001-08       Impact factor: 3.352

Review 9.  Biological activities of Curcuma longa L.

Authors:  C C Araújo; L L Leon
Journal:  Mem Inst Oswaldo Cruz       Date:  2001-07       Impact factor: 2.743

10.  Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation.

Authors:  B Cipriani; G Borsellino; H Knowles; D Tramonti; F Cavaliere; G Bernardi; L Battistini; C F Brosnan
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

View more
  20 in total

1.  Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice.

Authors:  Kunmu Zheng; Xiaoman Dai; Nai'an Xiao; Xilin Wu; Zhen Wei; Wenting Fang; Yuangui Zhu; Jing Zhang; Xiaochun Chen
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 2.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

Review 3.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins.

Authors:  Fred McMahon; Nessa Banville; David A Bergin; Christian Smedman; Staffan Paulie; Emer Reeves; Kevin Kavanagh
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

5.  Engineering Curcumin Biosynthesis in Poplar Affects Lignification and Biomass Yield.

Authors:  Barbara De Meester; Paula Oyarce; Ruben Vanholme; Rebecca Van Acker; Yukiko Tsuji; Thijs Vangeel; Sander Van den Bosch; Jan Van Doorsselaere; Bert Sels; John Ralph; Wout Boerjan
Journal:  Front Plant Sci       Date:  2022-07-04       Impact factor: 6.627

6.  Localized Immunosuppression With Tannic Acid Encapsulation Delays Islet Allograft and Autoimmune-Mediated Rejection.

Authors:  Jessie M Barra; Veronika Kozlovskaya; Eugenia Kharlampieva; Hubert M Tse
Journal:  Diabetes       Date:  2020-06-25       Impact factor: 9.461

7.  Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy.

Authors:  Shannon R M Kinney; Logan Carlson; Jennifer Ser-Dolansky; Chelsea Thompson; Sagar Shah; Amos Gambrah; Wei Xing; Sallie S Schneider; Clinton B Mathias
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Caloric restriction favorably impacts metabolic and immune/inflammatory profiles in obese mice but curcumin/piperine consumption adds no further benefit.

Authors:  Junpeng Wang; Sally M Vanegas; Xiaogang Du; Timothy Noble; Jean-Marc A Zingg; Mohsen Meydani; Simin Nikbin Meydani; Dayong Wu
Journal:  Nutr Metab (Lond)       Date:  2013-03-27       Impact factor: 4.169

Review 9.  Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.

Authors:  Stefanie Kewitz; Ines Volkmer; Martin S Staege
Journal:  Cancer Growth Metastasis       Date:  2013-08-08

10.  A systems biology pipeline identifies new immune and disease related molecular signatures and networks in human cells during microgravity exposure.

Authors:  Sayak Mukhopadhyay; Rohini Saha; Anbarasi Palanisamy; Madhurima Ghosh; Anupriya Biswas; Saheli Roy; Arijit Pal; Kathakali Sarkar; Sangram Bagh
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.